hydroxyurea
Showing 26 - 50 of 130
Brain and CNS Tumors Trial in France (hydroxyurea)
Completed
- Brain and Central Nervous System Tumors
- hydroxyurea
-
Bordeaux, France
- +4 more
Feb 19, 2021
Sickle Cell Disease Trial in Houston (Hydroxyurea)
Completed
- Sickle Cell Disease
- Hydroxyurea
-
Houston, TexasTexas Children's Hospital
Nov 16, 2020
Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA
Recruiting
- Sickle Cell Anemia
- +2 more
- CD3/CD19 depleted leukocytes
- +6 more
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
May 4, 2022
Thrombocythemia, Hemorrhagic Trial in Worldwide (Anagrelide, Hydroxyurea)
Completed
- Thrombocythemia, Hemorrhagic
- Anagrelide
- Hydroxyurea
-
Pleven, Bulgaria
- +14 more
May 13, 2021
Hemoglobin SC Disease Trial in Houston (hydroxyurea)
Terminated
- Hemoglobin SC Disease
- hydroxyurea
-
Houston, TexasTexas Children's Hospital
Sep 8, 2020
Idiopathic Pulmonary Fibrosis, Emphysema or COPD Trial in Pittsburgh (CD3/CD19 negative hematopoietic stem cells, Rituximab,
Recruiting
- Idiopathic Pulmonary Fibrosis
- Emphysema or COPD
- CD3/CD19 negative hematopoietic stem cells
- +6 more
-
Pittsburgh, Pennsylvania
- +1 more
Feb 9, 2022
HIV, AIDS Trial in Baltimore (Tenofovir, Hydroxyurea)
Completed
- HIV Infections
- AIDS
- Tenofovir
- Hydroxyurea
-
Baltimore, MarylandUniversity of Maryland, Institute of Human Virology
May 6, 2021
Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the
Active, not recruiting
- Human Papilloma Virus Infection
- +3 more
- paclitaxel albumin-stabilized nanoparticle formulation
- +8 more
-
Chicago, IllinoisUniversity of Chicago
Mar 2, 2022
HIV Trial in United States (Indinavir sulfate, Lamivudine/Zidovudine, Hydroxyurea)
Completed
- HIV Infections
- Indinavir sulfate
- +6 more
-
Birmingham, Alabama
- +33 more
Oct 27, 2021
HPV-Related Squamous Cell Carcinoma, HNSCC Trial in Chicago (drug, procedure, radiation)
Active, not recruiting
- HPV-Related Squamous Cell Carcinoma
- HNSCC
- nab-paclitaxel
- +12 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Nov 12, 2021
Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)
Recruiting
- Acute Promyelocytic Leukemia
- Realgar-Indigo naturalis formula
- +3 more
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Aug 31, 2021
Glioma, Glioblastoma Trial in Amsterdam (Hydroxyurea, Temozolomide)
Recruiting
- Glioma
- Glioblastoma
- Hydroxyurea
- Temozolomide
-
Amsterdam, Noord-Holland, NetherlandsVU University Medical Center
Oct 6, 2020
Hematologic Diseases, Anemia, Sickle Cell Trial in United States (Hydroxyurea, Placebo)
Completed
- Hematologic Diseases
- Anemia, Sickle Cell
- Hydroxyurea
- Placebo
-
Birmingham, Alabama
- +13 more
Aug 5, 2020
Sickle Cell Anemia, Sickle Cell Disease, Malaria Trial in Kampala (Hydroxyurea)
Completed
- Sickle Cell Anemia
- +2 more
- Hydroxyurea
-
Kampala, UgandaMulago Hospital Sickle Cell Clinic
Feb 19, 2020
Pulmonary Hypertension Trial (Hydroxyurea)
Withdrawn
- Pulmonary Hypertension
- Hydroxyurea
- (no location specified)
Dec 13, 2019
Sickle Cell Anemia, Sickle Cell Disease, Stroke Trial in Kano (Hydroxyurea)
Completed
- Sickle Cell Anemia
- +2 more
- Hydroxyurea
-
Kano, NigeriaAminu Kano Teaching Hospital
Jul 31, 2020
HIV Trial in United States (Hydroxyurea, Efavirenz, Stavudine)
Completed
- HIV Infections
- Hydroxyurea
- +3 more
-
Menlo Park, California
- +18 more
Oct 27, 2021
Sickle Cell Anemia Trial run by the NHLBI (Hydroxyurea)
Completed
- Sickle Cell Anemia
- Hydroxyurea
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019
Iron Overload, Oxidative Stress, Thalassemia Major Trial in Bani Suwayf, Mecca (Omega 3, Nigella Sativa Oil, Hydroxyurea)
Completed
- Iron Overload
- +2 more
- Omega 3
- +5 more
-
Banī Suwayf, Egypt
- +3 more
Jan 25, 2021
Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk
Recruiting
- Myelofibrosis
- +2 more
- Hematopoietic stem cell transplant
- +2 more
-
Calgary, Alberta, Canada
- +4 more
Feb 16, 2021